Viewing Study NCT00391495


Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2025-12-27 @ 10:47 AM
Study NCT ID: NCT00391495
Status: UNKNOWN
Last Update Posted: 2007-06-19
First Post: 2006-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Inflammation in Children With Attention-Deficit/Hyperactivity Disorder
Sponsor: Tel-Aviv Sourasky Medical Center
Organization:

Study Overview

Official Title: Inflammation in Children With Attention-Deficit/Hyperactivity Disorder
Status: UNKNOWN
Status Verified Date: 2006-08
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ADHD_CYTO
Brief Summary: The aim of this study is to investigate the inflammatory response in children with this disorder.
Detailed Description: Attention deficit-hyperactivity disorder (ADHD) is a prevalent childhood neuropsychiatric disorder, characterized by age-inappropriate and impairing levels of inattention, hyperactivity and impulsiveness. Approximately 5-10% of school-age children are affected by ADHD, and in many cases, symptoms persist into adolescence and adulthood.

Cytokines are key mediators of immune function and can be either pro-inflammatory or anti-inflammatory. Recently few studies have suggested involvement of cytokine pathways in subjects with ADHD.

Polymorphism of IL-1 receptors antagonists' alleles have been suggested in families and subjects suffering from ADHD. Moreover, a new variant of inflammatory bowel disease, another immunological based disease, was recently suggested in children with ADHD and other developmental disorders. There are no other published reports on cytokine production in children who suffer from ADHD.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: